Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Feasibility Study of the ReGenerCell™ Autologous Cell Harvesting Device for Diabetic Foot Ulcers

NCT02799121 is registered in ClinicalTrials.gov with Avita Medical as lead sponsor.

NCT NCT02799121
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02799121 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Feasibility Study of the ReGenerCell™ Autologous Cell Harvesting Device for Diabetic Foot Ulcers
Lead sponsor
Avita Medical
Phase
Phase 4
Overall status
Completed
Start date
May 31, 2016
Completion date
March 29, 2019
Enrollment
16 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

diabetic foot ulcer